Overview
Schizophrenia Trial of Aripiprazole
Status:
Completed
Completed
Trial end date:
2005-08-01
2005-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Aripiprazole will show improved effectiveness over the standard of care treatment with one of three atypical antipsychotics (olanzapine, quetiapine and risperidone).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.Collaborator:
Otsuka America PharmaceuticalTreatments:
AripiprazoleOlanzapine
Quetiapine Fumarate
Risperidone
Criteria
Inclusion Criteria:- Clinical diagnosis of schizophrenia
- Schizophrenia symptoms not optimally controlled or antipsychotic medication not well
tolerated
Exclusion Criteria:
- Diagnosis of schizoaffective disorder
- Patients treatment-resistant to antipsychotics